Delcath Systems Highlights Clinical Program Presentations at ESMO Congress 2026 and Independent Data on Percutaneous Hepatic Perfusion in Liver-Dominant Metastatic Uveal Melanoma
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
- Equities end higher as Anthropic's IPO filing buoys AI stocks
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
| DELCATH SYSTEMS (NASDAQ: DCTH) | Delayed: 14.51 +0.09 (0.62%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $14.42 | 52 Week High | $4.72 | |||
| Open | $14.41 | 52 Week Low | $0.22 | |||
| Day High | $14.72 | P/E | N/A | |||
| Day Low | $14.32 | EPS | $-102.40 | |||
| Volume | 232,857 | |||||
